These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29614419)

  • 1. Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity.
    Lu X; Wu YM; Yang JM; Ma FE; Li LP; Chen S; Zhang Y; Ni QL; Pan YM; Hong X; Peng Y
    Eur J Med Chem; 2018 May; 151():226-236. PubMed ID: 29614419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands.
    Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
    Eur J Med Chem; 2019 May; 169():103-110. PubMed ID: 30870791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
    Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
    Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
    Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
    Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted cyclometalated rhodium(III) complexes: synthesis, characterization and anticancer research.
    Peng YB; He W; Niu Q; Tao C; Zhong XL; Tan CP; Zhao P
    Dalton Trans; 2021 Jul; 50(26):9068-9075. PubMed ID: 34113944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of 6/8/11-Amino/Chloro-Oxoisoaporphine and Group-10 Metal Complexes and Evaluation of Their in Vitro and in Vivo Antitumor Activity.
    Qin QP; Qin JL; Meng T; Yang GA; Wei ZZ; Liu YC; Liang H; Chen ZF
    Sci Rep; 2016 Nov; 6():37644. PubMed ID: 27898051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Anticancer Evaluation of Some Synthesized 2H-Quinolinone and Halogenated 2H-Quinolinone Derivatives as Therapeutic Agents.
    El-Aziz RMA; Zaki I; El-Deen IM; Abd-Rahman MS; Mohammed FZ
    Anticancer Agents Med Chem; 2020; 20(18):2304-2315. PubMed ID: 32781965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
    Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
    Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-pyridinecarboxaldehyde thiosemicarbazones Ga(III) complexes with a high antiproliferative activity by promoting apoptosis and inhibiting cell cycle.
    Qi J; Deng J; Qian K; Tian L; Li J; He K; Huang X; Cheng Z; Zheng Y; Wang Y
    Eur J Med Chem; 2017 Jul; 134():34-42. PubMed ID: 28395152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation.
    Peng YB; Tao C; Tan CP; Zhao P
    J Inorg Biochem; 2021 May; 218():111400. PubMed ID: 33684684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
    Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
    Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for new biologically active compounds:
    Mitrović M; Djukić MB; Vukić M; Nikolić I; Radovanović MD; Luković J; Filipović IP; Matić S; Marković T; Klisurić OR; Popović S; Matović ZD; Ristić MS
    Dalton Trans; 2024 Jun; 53(22):9330-9349. PubMed ID: 38747564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro biological evaluation of three 4'-(4-methoxyphenyl)-2,2':6',2″-terpyridine iridium(III) complexes as new telomerase inhibitors.
    Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
    Eur J Med Chem; 2018 Jan; 143():1387-1395. PubMed ID: 29126737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy.
    Gu YQ; Yang K; Yang QY; Li HQ; Hu MQ; Ma MX; Chen NF; Liu YH; Liang H; Chen ZF
    J Med Chem; 2023 Jul; 66(14):9592-9606. PubMed ID: 37432720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
    Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
    Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Characterization, and Cytotoxicity of the Cobalt (III) Complex with N,N-Diethyl-4-(2,2':6',2''-terpyridin-4'-yl)aniline.
    Zou BQ; Wang SL; Qin QP; Bai YX; Tan MX
    Chem Biodivers; 2018 Oct; 15(10):e1800215. PubMed ID: 30027551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
    Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
    J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodium(iii) complexes with isoquinoline derivatives as potential anticancer agents: in vitro and in vivo activity studies.
    Khan TM; Gul NS; Lu X; Kumar R; Choudhary MI; Liang H; Chen ZF
    Dalton Trans; 2019 Aug; 48(30):11469-11479. PubMed ID: 31290881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines.
    Weber B; Serafin A; Michie J; Van Rensburg C; Swarts JC; Bohm L
    Anticancer Res; 2004; 24(2B):763-70. PubMed ID: 15161024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.